Bouza Carmen, López-Cuadrado Teresa, Almendro Nuria, Amate José María
Health-Care Technology Assessment Agency, Carlos III Institute of Health, Av. Monforte de Lemos 5, 28029, Madrid, Spain,
Eur Spine J. 2015 Apr;24(4):715-23. doi: 10.1007/s00586-014-3581-7. Epub 2014 Nov 16.
The study aims to evaluate the safety of balloon kyphoplasty in the treatment of painful osteoporotic vertebral compression fractures in Europe.
Systematic review of the literature, until September 2013, and meta-analysis of randomized controlled trials performed in Europe assessing the safety of balloon kyphoplasty in patients with symptomatic osteoporotic vertebral fractures. Outcomes sought include cement leaks, serious clinical complications and new vertebral fractures.
Six randomized controlled trials fulfilled the inclusion criteria. These studies included data on 525 treated levels in 424 patients. Cement leakages were detected in 18.3 % (95 % CI 11.6, 23.0) of fractures intervened. In about 0.5 % (95 % CI 0.1, 1.1) of fractures leakages proved to be symptomatic. Serious clinical complications were recorded in 11.5 % (95 % CI 1.1, 21.7) of patients treated with balloon kyphoplasty with several of these cases requiring intensive treatment or postoperative surgery. New vertebral fractures were detected in 20.7 % (95 % CI 0.4, 40.9) of patients treated but rates showed an upward pattern when the follow-up period increased. In 54 % of such cases, the fractures were located in regions adjacent to the treated level.
The safety profile and associated complications of balloon kyphoplasty shown in this analysis, based on the evidence provided by existing randomized controlled trials, can be of help to the practicing clinician who must contrast them with the potential benefits of the technique. These data represent an important step towards a balanced evaluation of the intervention though, a better reporting and more reliable data on long-term assessment of potential sequelae are needed.
本研究旨在评估欧洲地区球囊后凸成形术治疗疼痛性骨质疏松性椎体压缩骨折的安全性。
对截至2013年9月的文献进行系统回顾,并对欧洲开展的评估球囊后凸成形术治疗有症状的骨质疏松性椎体骨折安全性的随机对照试验进行荟萃分析。所寻求的结果包括骨水泥渗漏、严重临床并发症和新的椎体骨折。
六项随机对照试验符合纳入标准。这些研究纳入了424例患者525个治疗节段的数据。在接受干预的骨折中,18.3%(95%可信区间11.6,23.0)检测到骨水泥渗漏。约0.5%(95%可信区间0.1,1.1)的骨折渗漏有症状。接受球囊后凸成形术治疗的患者中,11.5%(95%可信区间1.1,21.7)记录到严重临床并发症,其中一些病例需要强化治疗或术后手术。接受治疗的患者中,20.7%(95%可信区间0.4,40.9)检测到新的椎体骨折,但随着随访期延长,发生率呈上升趋势。在54%的此类病例中,骨折位于治疗节段相邻区域。
基于现有随机对照试验提供的证据,本分析显示的球囊后凸成形术的安全性概况及相关并发症,可为临床医生提供帮助,使其能将这些情况与该技术的潜在益处进行对比。尽管这些数据是朝着平衡评估该干预措施迈出的重要一步,但仍需要更好地报告以及关于潜在后遗症长期评估的更可靠数据。